article thumbnail

PBMs and insurers want your prescription money

World of DTC Marketing

anti-kickback law that the drugmaker said prevented it from helping heart failure patients, many with low incomes, afford the medicine that costs $225,000 annually. For many, these coupons represent the difference between filling a prescription and going without lifesaving care, but there is a lot more here than just a co-pay coupon.

Insurance 226
article thumbnail

In Europe, shortages of Novo Nordisk's Ozempic to persist into Q4: letter

Fierce Pharma

The company and the European Medicines Agency warned European healthcare providers to continue limiting new patient prescriptions until the shortages let up.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business

MedCity News

The post Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business appeared first on MedCity News. In part 2 of our Q&A, Okamura addresses the need for biopharma companies to leverage digital technologies in disease management.

article thumbnail

2022 Prescription Trends

PharmExec

The market for prescription medicines in the United States was subject to major shifts in use across therapeutic areas in 2022, reflecting changes in patient health needs, the development, and availability of novel medicines, and complex market dynamics.

article thumbnail

NationsBenefits Acquires Good Measures to Advance Food-as-Medicine Offerings

MedCity News

To ramp up its food-as-medicine support, NationsBenefits has acquired Good Measures, a company that offers coaching and personalized food prescriptions. The post NationsBenefits Acquires Good Measures to Advance Food-as-Medicine Offerings appeared first on MedCity News.

Food 127
article thumbnail

After similar moves in Kenya and India, GSK telegraphs commercial halt in Nigeria

Fierce Pharma

GSK said it plans to cease commercialization of its prescription medicines and vaccines in Nigeria, with the intent to switch to a third-party direct distribution model. After charting a similar move in Kenya last year, GSK is pulling the plug on its Nigerian operations. |

article thumbnail

GoodRx Launches Solution To Help Consumers Manage Their Prescriptions

MedCity News

Medicine Cabinet, a new solution by GoodRx, gives users reminders to take their medications and refill prescriptions and recommends pharmacies based on prescription costs. It also has a rewards system for using GoodRx coupons and picking up prescriptions on time.